Jennifer Doudna

Biochemist Faculty Scientist
Professor, University of California, Berkeley
Principal Investigator, Howard Hughes Medical Institute

Molecular Biophysics and Integrated Bioimaging

Structural Biology

Building: 2151 Berkeley Way, Room 512G
Phone: (510) 643-0113
JDoudna@lbl.gov
http://rna.berkeley.edu

Curriculum Vitae

Research Interests

Molecular and Cell Biology and Chemistry

Selected Publications

LinkedIn Profile

Was this page useful?

Send

CRISPR Voted Top Breakthrough at Berkeley Lab

August 30, 2021

In celebration of the Lab’s 90th anniversary, 16 of our most popular “90 Breakthroughs” faced off in the first ever Berkeley Lab Breakthroughs Bracket Challenge on Twitter. After four weeks of public voting online, the top breakthrough was “Created a Powerful Gene Editing Tool”—otherwise known as CRISPR!

Jennifer Doudna and the Nobel Prize: The Advanced Light Source Perspective

October 23, 2020

Emmanuelle Charpentier and Jennifer Doudna winning the 2020 Nobel Prize for Chemistry for their development of the CRISPR method of genome editing is a momentous achievement, supported by the contributions of numerous individuals and institutions, including the Advanced Light Source (ALS) synchrotron user facility at Berkeley Lab. This feature details how Doudna’s research was enabled by the facility’s early embrace of hard X-ray crystallography technology for atomic-level understanding of molecular structure, as well as her use of the Berkeley Center for Structural Biology’s (BCSB’s) wiggler-based beamline 5.0.2 for macromolecular crystallography. Doudna has published some 35 papers using ALS crystallography beamlines, including two cited by the Nobel Committee in its CRISPR-Cas9 scientific background document.

Doudna Awarded 2020 Nobel Prize in Chemistry

October 7, 2020

Biochemist Jennifer Doudna, a professor at UC Berkeley and faculty scientist in the Molecular Biophysics and Integrated Bioimaging Division, has been awarded the 2020 Nobel Prize in Chemistry for “the development of a method for genome editing.” She shares the Nobel Prize with co-discoverer Emmanuelle Charpentier, who currently serves as the scientific and managing director of the Max Planck Unit for the Science of Pathogens in Berlin. In 2012, Doudna and Charpentier’s research team detailed the underlying mechanisms of the CRISPR-Cas9 system – a component of the bacterial immune system that defends against invading viruses – and explained how it can be programmed to cut DNA at a target sequence.